Objectives: The goal of this study was to evaluate the safety and performance of the Multi-Link Frontier coronary bifurcation stent system (Guidant Corp., Santa Clara, California), a novel dedicated device designed for permanent side branch (SB) access, stent delivery by simultaneous kissing balloon inflation, and optimal main branch (MB) and SB ostium scaffolding.
Background: The treatment of coronary bifurcation lesions remains challenging, and various approaches using stents have been proposed.
Methods: The primary end point was the 180-day incidence of major adverse cardiac events (MACE) per intent-to-treat analysis. Secondary end points included device success, 30-day MACE, angiographic restenosis, and target lesion revascularization (TLR) rates at 180 days.
Results: After a learning phase of two cases per center, 105 patients were prospectively included in 11 centers. The left anterior descending coronary artery/diagonal bifurcation was the target in 80% of cases. The Frontier stent was successfully implanted in 96 patients (91%), and procedural success was obtained in 93%. Two patients suffered in-hospital myocardial infarction (MI) secondary to SB occlusion, and one patient underwent elective coronary artery bypass grafting. At 30 days and 6 months, the MACE rates were 2.9% and 17.1% (no death, no subacute stent thrombosis, Q-wave MI 1.0% and 1.9%, non-Q-wave MI 1.0% and 1.9%, TLR 1.0% and 13.3%). The MB in-stent restenosis was 25.3%, in-segment 29.9%. The SB restenosis was 29.1%. The overall restenosis rate for any branch was 44.8%.
Conclusions: The results of this Frontier registry demonstrate the safety and performance of this dedicated stent system for the treatment of bifurcation lesions. The device can be successfully implanted in more than 90% of all cases, with a high procedural success rate and low 30-day and 6-month MACE rates.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jacc.2005.05.033 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association of perioperative P2Y inhibitor administration with outcomes for tandem occlusion: RESCUE AT-LVO sub-study.
Front Neurol
November 2024
Department of Neurosurgery, Hyogo Medical University, Nishinomiya, Japan.
Background: We aimed to clarify the association between intraoperative P2Y inhibitor administration during EVT and clinical outcomes in patients with anterior circulation TO stroke.
Methods: Among consecutive patients with acute ischemic stroke (AIS) enrolled in the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolic and Atherothrombotic Stroke with Large Vessel Occlusion Registry from 2016 to 2019, those with anterior circulation TOs who underwent EVT were analyzed. These patients were categorized into the following groups: those who received P2Y inhibitors during the perioperative period and those who did not receive P2Y inhibitors.
New Frontiers for Orbital Atherectomy-Crossing an Uncrossable Chronic Total Occlusion.
Catheter Cardiovasc Interv
December 2024
Department of Cardiology, Kettering General Hospital, Interventional Cardiologist, Kettering, Northamptonshire, UK.
Article Synopsis
- Managing chronic total occlusions (CTOs) in coronary artery disease is challenging, particularly when standard techniques don't work on lesions that are difficult to cross.
- A 62-year-old male patient with exertional chest pain had multiple conventional treatments fail to address a CTO in his right coronary artery, highlighting the difficulty of these types of lesions.
- The use of orbital atherectomy with the DiamondBack 360 system finally allowed successful treatment by crossing the CTO, showcasing its potential as a valuable option for complex cases where traditional methods have failed.
A systematic review of surgical and interventional radiology procedures for pediatric idiopathic intracranial hypertension.
Front Pediatr
October 2024
Pediatric Neurology and Neurophysiology Unit, Department of Women's and Children's Health, University Hospital of Padua, Padua, Italy.
Background: Idiopathic intracranial hypertension (IIH) is defined as elevated intracranial pressure and consequent symptoms (mainly headache and visual deterioration) occurring in the absence of secondary causes. Surgical and interventional radiology procedures should be considered for refractory IIH and mainly include cerebrospinal fluid (CSF) diversion techniques, optic nerve sheath fenestration (ONSF), and venous sinus stenting (VSS). Our study aims to review the current literature on the application of these techniques in clinical practice.
View Article and Find Full Text PDFEditorial: Community series in frozen elephant trunk surgery in aortic dissection: volume II.
Front Cardiovasc Med
October 2024
Minimally Invasive Cardiac Surgery Unit, IRCCS Ospedale Galeazzi - Sant'Ambrogio, Milan, Italy.
Use of Onyx Frontier for intracranial stenting in stroke patients: A multicenter retrospective study.
Interv Neuroradiol
October 2024
Department of Neurology, University of Chicago, Chicago, IL, USA.
Background: Acute ischemic stroke (AIS) due to intracranial atherosclerotic disease (ICAD) carries a high risk of recurrence despite aggressive medical management. The aim of our study is to present our initial experience with the Onyx Frontier™ balloon-mounted drug-eluting stent (Medtronic, Santa Rosa, CA) for AIS due to ICAD.
Methods: We conducted a multicenter retrospective cohort study describing the technical feasibility, safety, and performance of using the Onyx Frontier™ balloon-mounted drug-eluting stent in patients with acute intracranial vessel occlusion due to ICAD across three comprehensive stroke centers in the United States.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!